Background: FNA is a cost-effective and minimally invasive diagnostic tool for sampling salivary gland lesions. However due to intra-tumoral heterogeneity and frequent overlapping of cyto-morphologic features precise subtyping of neoplasms can be challenging. To address this, International panel of experts under the joint effort of the American society of cytopathology and the International academy of cytology developed the MSRSGC. Methodology: 356 salivary gland FNA samples were retrospectively analysed and re-categorised into 6 categories of the Milan system. Histopathology diagnoses were retrieved wherever available. Overall ROM were calculated for each category. Results: On re-categorising into the Milan system, 62 cases were assigned to non-diagnostic category (17.4%), 67 to non-neoplastic category (18.8%), 48 as Atypical (13.5%), 101 as benign neoplasms (28.4%), 35 to the salivary gland neoplasm of uncertain malignant potential (9.8%), 16 as suspicious for malignancy (4.5%) and 27 to the malignant category (7.6%).The ROM for above mentioned category were 30%, 7.1%, 14.2%, 3%, 31%, 67% and 95.2% respectively. Conclusion: MSRSGC provides uniform reporting system for salivary gland cytopathology which helps to reduce reporting ambiguities and thus improves overall patient care.
Introduction
Salivary gland neoplasm comprise approximately 6.5% of the lesions sampled in the head and neck, out of which approximately 40% are malignant 1 
.
A multimodal approach is required as a part of initial diagnostic work-up for salivary gland nodules. However, to finalise the malignant potential of a lesion, fine-needle aspiration (FNA) remains the preferred diagnostic test [1] [2] [3] [4] [5] [6] [7] [8] [9] .
Fine needle aspiration (FNA) of salivary gland is a cost-effective and minimally invasive diagnostic technique in guiding the management of superficial masses [10] [11] [12] [13] . Despite the above mentioned advantages, there exist few limitations, including the lack of architecture and cellular complexity of salivary gland neoplasms encountered among the same subtypes and even within an individual tumor [17] [18] [19] .
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In an attempt to address some of these limitations of salivary gland FNA a group of International pathologists proposed a uniform system known as The Milan system for reporting salivary gland cytopathology (MSRSGC) 14 . Similar to analogous reporting schemes, like the Bethesda System for Reporting Thyroid Cytopathology, this classification system considers the reporting ambiguities inherent to salivary gland pathology, while also risk stratifying lesions, providing a clinical useful guidelines regarding its management 16 .The MSRSGC is composed of seven diagnostic categories: non-diagnostic, non-neoplastic, atypia of undetermined significance, benign neoplasm, salivary gland neoplasm of uncertain malignant potential, suspicious for malignancy, and malignant. As the MSRSGC is still in its infancy, additional studies are needed to evaluate the effectiveness of this classification system 15 . The main objective of this study was to assess the diagnostic accuracy of salivary gland FNAs using the Milan System and evaluate the MSRSGC as a tool for risk assessment.
Materials and Methods
FNA specimens from salivary gland lesions that were registered from January 2016 to September 2018 in the cytology department at Mysore medical college and research institute were retrieved. Oral informed consent was obtained from each patient before routine FNA of salivary gland lesions. FNA procedure were performed by trained cytopathologist. Major and minor salivary gland swellings, including intraoral lesions, were aspirated via direct percutaneous or trans-oral route with 23-27gauge needle. Smears were stained with haematoxylin and eosin stains in all cases for immediate on-site evaluation, and few of the direct smears were stained with the Papanicolaou stain following alcohol fixation. All data related to cytological examination, history, clinical examination and investigations were collected. FNA diagnoses were retrospectively classified according to the Milan system as follows: 
Results
A total of 356 FNA specimens were identified between January 2016 and September 2018 which included 189 females and 167 males (female:male ratio of 1.1:1) with an average age of 52 years (range 12-90 years). The most frequent site of involvement was the parotid gland (232/356, 65.1%), followed by the submandibular gland (118/356, 33.1%), and last the minor salivary glands (6/356, 1.7%). The pre-operative cytology classifications and histologic follow-up are summarized in (Table 1) . For the FNA cases with surgical follow-up, the risks of neoplasm and malignancy were calculated for each of the Milan System diagnostic categories ( Table 1 ). The most common benign and malignant diagnoses in each category are listed in (Table 2) . Discordance between FNA and histologic diagnoses was observed in 5 cases. In the nonneoplastic FNA group, 1/14 (7.1%) case was ultimately diagnosed as lipoma and 1/14 (7.1%) were diagnosed as lymphoma. Among cases called benign neoplasm on FNA, 2/67 (3.0%) were reported to be malignant on resection which included cases of adenoid cystic carcinoma and mucoepidermoid carcinoma.
Finally, of cases called malignant on FNA, 1/21 (4.8%) was Warthin tumor on histologic followup. Malignancies represented by the AUS category included lymphoma (2), mucoepidermoid carcinoma (2), squamous cell carcinoma (1) and adenoid cystic carcinoma (1) . Non-neoplastic entities included lymphoepithelial cyst (4), benign salivary gland tissue (6), sialadenitis (2) and reactive lymphoid tissue (2) . The overall sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were 82.4%, 96.2%, 89.4%, and 100%, respectively. 
Discussion
Despite widespread acceptance of FNA as first line diagnostic approach in patients with salivary gland lesion, it remains one of the most challenging areas within cytopathology 6, 8, 9, [20] [21] [22] [23] [24] [25] . Hence there is a need for application of standardised system for reporting salivary gland FNA, which would help to optimise the clinical utility of this test. Similar to Bethesda system for reporting thyroid cytopathology, the MSRSGC represents a tiered classification system that provides diagnostic information, risk assessment, and management guidelines 17 . In this retrospective study, we found MSRSGC are fairly easy to adopt in daily practise.
In our study, we found 17 Milan system also provides management guidelines, under which non-neoplastic category were monitored without surgical follow-up whereas atypical to malignant category had surgical follow-up.
The major limitation of our study is its retrospective nature, which might lead to bias in assigning cases according to the Milan system, particularly when histologic follow-up was already known. However due to limited acceptance of the Milan system in most of the institutions, retrospective study remains to be the main mode of assessing this study.
Conclusion
The recently proposed MSRSGC represents a standardised method for reporting salivary gland FNA. It is a uniform system accepted internationally for reporting salivary gland FNA. It helps to bring in better communication between cytopathologists and treating clinicians also between institutions, thus result in overall improved patient care. However, larger studies with clinical follow-up are required to determine the overall accuracy of MSRSGC.
